Guangdong Jiaying Pharmaceutical Co., Ltd

SZSE:002198 Stock Report

Market Cap: CN¥4.0b

Guangdong Jiaying Pharmaceutical Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Guangdong Jiaying Pharmaceutical.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth18.9%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Revenues Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) After Shares Rise 31%

Nov 20
Revenues Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) After Shares Rise 31%

Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Jiaying Pharmaceutical (SZSE:002198)

Nov 06
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Jiaying Pharmaceutical (SZSE:002198)

Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Jul 03
Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

There May Be Reason For Hope In Guangdong Jiaying Pharmaceutical's (SZSE:002198) Disappointing Earnings

May 03
There May Be Reason For Hope In Guangdong Jiaying Pharmaceutical's (SZSE:002198) Disappointing Earnings

Earnings Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198)

Mar 12
Earnings Not Telling The Story For Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Guangdong Jiaying Pharmaceutical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:002198 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024416122964N/A
6/30/2024456225579N/A
3/31/202449927100112N/A
12/31/2023533349398N/A
9/30/2023622477579N/A
6/30/2023670544347N/A
3/31/2023667542225N/A
1/1/2023659442427N/A
9/30/2022587192629N/A
6/30/202256966467N/A
3/31/2022573-45356N/A
1/1/202257514952N/A
9/30/2021592258389N/A
6/30/2021589277985N/A
3/31/202157426102114N/A
12/31/2020545208597N/A
9/30/2020518-14311379N/A
6/30/2020494-1399363N/A
3/31/2020505-129322N/A
12/31/2019501-122-613N/A
9/30/201954040-5012N/A
6/30/201953838-3029N/A
3/31/2019531363240N/A
12/31/2018537365362N/A
9/30/2018510-2114755N/A
6/30/2018495-213N/A32N/A
3/31/2018483-214N/A39N/A
12/31/2017468-215N/A31N/A
9/30/201746948N/A42N/A
6/30/201747149N/A58N/A
3/31/201745555N/A46N/A
12/31/201645055N/A53N/A
9/30/201643245N/A28N/A
6/30/201642150N/A43N/A
3/31/201644560N/A46N/A
12/31/201547666N/A42N/A
9/30/201549065N/A38N/A
6/30/201552474N/A43N/A
3/31/201554471N/A89N/A
12/31/201456674N/A103N/A
9/30/2014529174N/A98N/A
6/30/2014428164N/A67N/A
3/31/2014323154N/A20N/A
12/31/2013227139N/A19N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002198's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 002198's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002198's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002198's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002198's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 002198's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y